Brookdale Senior Living Inc. (BKD) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with a 19% increase in EBITDA, improved occupancy, and positive RevPAR growth. Despite missing free cash flow guidance, the company shows progress in leverage reduction and resident satisfaction. The Q&A highlights strategic initiatives like HealthPlus expansion and a centralized pricing strategy, which bolster growth prospects. While some guidance details were vague, overall sentiment is positive with raised EBITDA guidance, occupancy gains, and strategic focus on operational efficiency. Given the market cap, a positive stock price reaction of 2% to 8% is expected over the next two weeks.
Key Financial Performance
RevPAR growth 5.7% for 2025, at the top end of initial guidance. This was driven by positive occupancy and pricing trends.
Adjusted EBITDA $458 million for 2025, a 19% year-over-year increase. This exceeded initial expectations and marked the fourth consecutive year of double-digit growth. Growth was attributed to improved occupancy and operational efficiencies.
Occupancy 82.5% weighted average for Q4 2025, a 310 basis point improvement year-over-year. Growth was supported by market demand, internal focus on occupancy, and SWAT team initiatives.
Adjusted Free Cash Flow $23 million for 2025, marking the first positive year since 2020. Fell short of the $30-$50 million guidance due to working capital timing and refinancing-related interest prepayments.
Nondevelopment CapEx $170.7 million for 2025, focused on community reinvestments to improve NOI and aesthetics.
Leverage 8.9x adjusted EBITDA at the end of 2025, improved from 9.9x in 2024. Improvement was driven by adjusted EBITDA growth.
Resident Fees $3 billion for 2025, a 2.4% year-over-year increase. Growth was driven by a 5.7% increase in RevPAR, offset by a 3.2% decline in available units due to portfolio optimization.
Net Promoter Score (NPS) Increased by 19 points since 2022, reflecting improved resident satisfaction.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Brookdale HealthPlus Expansion: Expanded into 58 additional communities across 8 states, including 3 new states, bringing the total to over 180 communities served.
Demographic Trends: The population of 80+ year-old Americans is expected to grow at a 4%+ compounded annual rate for the next decade, while senior housing supply growth is at a historical low of 0.6%.
Occupancy Growth: Achieved a weighted average occupancy of 82.5% in Q4 2025, the highest since Q1 2020, with a 310 basis point improvement year-over-year.
Adjusted EBITDA Growth: Grew adjusted EBITDA by 19% to $458 million in 2025, marking the fourth consecutive year of double-digit growth.
Portfolio Optimization: Exited 58 leased communities and sold 12 owned communities in 2025, with plans to sell 29 more owned communities in 2026, generating approximately $200 million in proceeds.
Operational Restructuring: Introduced a new regional operating structure with 6 leadership teams and created a Senior VP of Strategic Operations role to centralize pricing, labor management, and capital investment decisions.
Leverage Reduction: Reduced adjusted annualized leverage to 8.9x in 2025, with a goal to bring it below 6x by 2028.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Occupancy Challenges: Despite improvements, 80 communities remain below the 70% occupancy threshold, with 14 expected to be sold and 21 requiring intervention from SWAT teams. This indicates ongoing challenges in achieving optimal occupancy levels.
Portfolio Optimization Risks: The company plans to sell 29 owned communities by mid-2026, which could disrupt operations and revenue streams during the transition period.
Leverage and Debt Management: Brookdale's adjusted annualized leverage remains high at 8.9x adjusted EBITDA, posing financial risks despite improvements. The company aims to reduce leverage to under 6x by 2028, but this is contingent on sustained EBITDA growth.
Labor Costs and Turnover: Labor remains the largest cost item at 65% of facility operating expenses. While turnover has improved, it still poses a risk to operational stability and cost management.
Economic and Market Conditions: The company is reliant on demographic trends and limited senior housing supply for growth. Any adverse changes in these conditions could impact occupancy and revenue.
Regulatory and Compliance Risks: Brookdale operates in a highly regulated industry, and any changes in regulations or compliance requirements could increase costs or limit operational flexibility.
Capital Investment Risks: The company plans to invest $175 million to $195 million in non-development capital projects in 2026. Mismanagement or delays in these investments could impact community-level NOI and occupancy growth.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Per Available Room (RevPAR) Growth: Brookdale is projecting RevPAR growth of 8% to 9% for 2026, driven by higher in-place rate increases, strong move-in demand, and the accretive impact of disposition communities.
Adjusted EBITDA: Brookdale expects adjusted EBITDA to grow to a range of $502 million to $516 million in 2026, representing mid-teen annual growth from the 2025 baseline of $445 million. The company also anticipates maintaining mid-teens adjusted EBITDA growth through 2028.
Occupancy Rates: Occupancy is expected to continue improving, supported by strong move-in demand and demographic trends. The company anticipates further income flow-through as occupancy increases beyond the 80% level, which is pivotal for leveraging fixed costs.
Capital Expenditures: Brookdale plans to invest $175 million to $195 million in nondevelopment capital projects in 2026, focusing on community improvements that enhance occupancy and NOI.
Portfolio Optimization: Brookdale anticipates completing the sale of 29 owned communities by mid-2026, generating approximately $200 million in proceeds. This will streamline the portfolio to 517 owned and leased communities, improving occupancy, RevPAR, and adjusted EBITDA.
Leverage Reduction: Brookdale aims to reduce leverage to under 6x by the end of 2028, primarily through adjusted EBITDA expansion. The adjusted annualized leverage at the end of 2025 was 8.9x, down from 9.9x in the prior year.
Market Trends and Demographics: The population of Americans aged 80 and above is expected to grow at a 4% compounded annual rate over the next decade, while senior housing supply growth remains historically low at 0.6%. This imbalance is expected to drive increasing occupancy across the senior living industry.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What progress is being made in transitioning to an operating company, and can you provide specific examples?
A:Nikolas Stengle explained that the company is focusing on becoming an operating company with a dedicated COO, Mary Sue, and regional teams. They have hired a Senior Vice President of Strategic Operations to consolidate pricing, labor management, and CapEx decision-making. The regional model includes six regional leaders with dedicated teams for sales, clinical, asset management, and dining to make hyper-local decisions.
Q:What are the targets for HealthPlus rollouts in 2026, and have you analyzed data on rents, rent increases, or retention in communities with HealthPlus?
A:Nikolas Stengle stated that HealthPlus will expand to additional communities in 2025 and focus on filling gaps in markets like Kansas City and Dallas. The program has improved resident retention by reducing hospital visits and emergency room usage. It has also positively impacted associate turnover rates and move-ins, as family members appreciate the benefits of the program.
Q:What is the centralized pricing strategy, and have there been financial-related move-outs due to rent increases?
A:Nikolas Stengle mentioned that in-place rent increases for 2026 are in the mid to high single digits, similar to two years ago. Mary Sue added that financial-related move-outs are in line with previous years, and attrition rates have been favorable, continuing to decline over the last two years.
Q:Can you provide more details on non-development CapEx and the timeline for addressing all locations needing CapEx?
A:Nikolas Stengle explained that ongoing real estate reinvestment is necessary, with a focus on larger projects in key markets like Dallas and Kansas City. The company has prioritized high-impact projects and plans to maintain a similar CapEx run rate in the future.
Q:What are the plans for improving occupancy in the 70-80% band, and what factors are being considered?
A:Nikolas Stengle stated that the SWAT teams are focusing on communities in the 70-80% occupancy band to push them above 80%. Efforts include CapEx, pricing, and reducing associate turnover. Some communities in this band are also on the disposition list.
Q:How has the recent winter storm affected occupancy, and what does it indicate about demand?
A:Nikolas Stengle noted that the storm impacted move-ins in January, but February numbers are already showing recovery. The demand for senior living remains strong, and combining January and February data provides a better picture of Q1 performance.
Q:What is the CapEx spend per unit, and is this a structural or cyclical increase?
A:Nikolas Stengle and Dawn Kussow clarified that the CapEx spend is around $3,500-$4,400 per unit, with a focus on targeted investments in specific communities. This approach represents a structural shift rather than a cyclical increase.
Q:What trends are being observed in resident acuity and length of stay?
A:Mary Sue and Nikolas Stengle explained that resident acuity levels have decreased since COVID, leading to longer lengths of stay. Higher acuity residents moving out and lower acuity residents moving in have impacted RevPOR, but overall occupancy growth is supported by decreasing turnover rates and increasing lengths of stay.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numbers or detailed timelines for CapEx beyond 2026, stating only that the run rate feels comfortable. They also did not disclose specific markets or communities targeted for CapEx investments, citing strategic reasons.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Americans
Brookdale HealthPlus
Brookdale Senior
Brookdale improvement
Brookdale level
Chief Officer
HealthPlus platform
Investor Day
Investor Relations
Officer Patchett
SWAT team
advance Investor
associate measure
baby boomer
capital investment
community occupancy
estate
event
food
function
investment community
investor
leader
leverage end
living
nondevelopment capital
objective
occupancy band
outlook year
point improvement
project
state
today Brookdale
trend occupancy
BKD Transcript
Brookdale Senior Living Inc. (BKD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-13
Brookdale Senior Living Inc. (BKD) Q1 2026 Earnings Call Transcript
Positive5-8
The earnings call summary reveals positive aspects such as strong RevPAR growth, EBITDA improvement, and effective cost management. The Q&A indicates confidence in guidance and strategic CapEx investments. While there are concerns about move-outs and unclear responses on storm impacts, the overall sentiment is positive. The market cap suggests moderate sensitivity to these factors. The strategic plan and positive financial metrics hint at a positive market reaction, though not overwhelmingly so, leading to a 'Positive' sentiment prediction for the stock price over the next two weeks.
Brookdale Senior Living Inc. (BKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral3-10
Brookdale Senior Living Inc. (BKD) Q4 2025 Earnings Call Transcript
Positive2-19
The earnings call reveals strong financial performance with a 19% increase in EBITDA, improved occupancy, and positive RevPAR growth. Despite missing free cash flow guidance, the company shows progress in leverage reduction and resident satisfaction. The Q&A highlights strategic initiatives like HealthPlus expansion and a centralized pricing strategy, which bolster growth prospects. While some guidance details were vague, overall sentiment is positive with raised EBITDA guidance, occupancy gains, and strategic focus on operational efficiency. Given the market cap, a positive stock price reaction of 2% to 8% is expected over the next two weeks.
BKD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
